Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
International Journal of Cancer|August 12, 2004
Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: identification of candidate molecular markers for ovarian cancer diagnosis and therapyAlessandro D Santin, Fenghuang Zhan, Stefania Bellone, et al.
Scientific Reports|January 31, 2023
Functional profiles of curatively treated adenoid cystic carcinoma unveil prognostic features and potentially targetable pathwaysChiara Romani, Luigi Lorini, Anna Bozzola, et al.
Clinical Chemistry and Laboratory Medicine|September 10, 2013
Cancer antigen 125, human epididymis 4, kallikrein 6, osteopontin and soluble mesothelin-related peptide immunocomplexed with immunoglobulin M in epithelial ovarian cancer diagnosisElisabetta Bandiera, Laura Zanotti, Aline S C Fabricio, et al.
Oncotarget|September 30, 2015
Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug deliveryChiara Romani, Emiliano Cocco, Eliana Bignotti, et al.
Cancers|July 20, 2021
Comprehensive Profiling of Hypoxia-Related miRNAs Identifies miR-23a-3p Overexpression as a Marker of Platinum Resistance and Poor Prognosis in High-Grade Serous Ovarian CancerPaola Todeschini, Elisa Salviato, Chiara Romani, et al.
Frontiers in Immunology|July 5, 2021
Infiltration by CXCL10 Secreting Macrophages Is Associated With Antitumor Immunity and Response to Therapy in Ovarian Cancer SubtypesLaura Ardighieri, Francesco Missale, Mattia Bugatti, et al.
Proteomics|October 15, 2014
Functional characterization of epithelial ovarian cancer histotypes by drug target based protein signaling activation mapping: implications for personalized cancer therapyMaria Isabella Sereni, Elisa Baldelli, Guido Gambara, et al.
Journal of Translational Medicine|July 4, 2013
Secretoglobin expression in ovarian carcinoma: lipophilin B gene upregulation as an independent marker of better prognosisEliana Bignotti, Renata A Tassi, Stefano Calza, et al.
BMC Cancer|May 18, 2021
Immunotherapy for the prevention of high-risk oral disorders malignant transformation: the IMPEDE trialCristina Gurizzan, Luigi Lorini, Alberto Paderno, et al.
Frontiers in Oncology|August 28, 2020
Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma PatientsChiara Romani, Valentina Zizioli, Marco Silvestri, et al.
Pageof 8